Interventions for valvular disease and heart failure

Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER Cardiac Plug

EuroIntervention 2016;11:1170-1179 published online ahead of print January 2015 ]. DOI: 10.4244/EIJY15M01_06

Apostolos Tzikas
Apostolos Tzikas1,2*, MD, PhD; Samera Shakir3, MD; Sameer Gafoor4, MD; Heyder Omran5, MD; Sergio Berti6, MD; Gennaro Santoro7, MD; Joelle Kefer8, MD; Ulf Landmesser9, MD; Jens Erik Nielsen-Kudsk10, MD; Ignacio Cruz-Gonzalez11, MD; Horst Sievert4, MD; Tobias Tichelbäcker12, MD; Prapa Kanagaratnam13, MD; Fabian Nietlispach3,9, MD; Adel Aminian14, MD; Friederike Kasch15, MD; Xavier Freixa16,17, MD; Paolo Danna18, MD; Marco Rezzaghi6
1. AHEPA University Hospital, Thessaloniki, Greece; 2. Interbalkan European Medical Center, Thessaloniki, Greece; 3. University Hospital of Bern, Bern, Switzerland; 4. CardioVascular Center Frankfurt, Frankfurt, Germany; 5. University Hospital of Bonn, Bo

Aims: To investigate the safety, feasibility, and efficacy of left atrial appendage occlusion (LAAO) with the AMPLATZER Cardiac Plug (ACP) for stroke prevention in patients with atrial fi

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

bleedingleft atrial appendage closurestroke risk
Interventions for strokeLAA closureTools, devices and techniques
Read next article
Incidence and clinical impact of infective endocarditis after transcatheter aortic valve implantation

Latest news